Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 12/20 | 0.39 |
| ▸ | CTSD | P07339 | 1/20 | 0.36 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.34 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29630322 | 0.96 | BACE1 (0.41) | BACE1CTSDOPRD1PTPN1 | |
| SCHEMBL29591626 | 0.96 | BACE1 (0.41) | BACE1CTSDOPRD1PTPN1 | |
| SCHEMBL29376470 | 0.94 | MME (0.36) | BACE1 | |
| SCHEMBL29447737 | 0.93 | MME (0.36) | BACE1 | |
| SCHEMBL30390019 | 0.91 | MME (0.39) | BACE1 | |
| SCHEMBL31314295 | 0.90 | BACE1 (0.44) | BACE1CTSDOPRD1PTPN1 | |
| SCHEMBL29557496 | 0.90 | BACE1 (0.38) | BACE1CTSDOPRD1PTPN1 | |
| SCHEMBL30426633 | 0.90 | OPRD1 (0.35) | BACE1OPRD1 | |
| SCHEMBL31113501 | 0.90 | BACE1 (0.35) | BACE1OPRD1 | |
| SCHEMBL29630382 | 0.90 | BACE1 (0.36) | BACE1CTSD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12618102-B2 | Biochemical reaction methods and reagents comprising intrinsically disordered regions | Biocrucible Limited (GB) | 2026-05-05 | — | — | US | disclosed |
| US-20220112547-A1 | BIOCHEMICAL REACTION METHODS AND REAGENTS COMPRISING INTRINSICALLY DISORDERED REGIONS | Biocrucible Limited (GB) | 2022-04-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12618102-B2 | Biochemical reaction methods and reagents comprising intrinsically disordered regions | POLM, POLR1A, POLR1E | BACE1 530/4885CTSD 3399/4885OPRD1 4566/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.